Literature DB >> 26264174

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Alexander Storch1,2,3, Christine B Schneider4, Lisa Klingelhöfer4, Per Odin5,6, Gerd Fuchs7, Wolfgang H Jost8, Pablo Martinez-Martin9, Rainer Koch10, Heinz Reichmann11, K Ray Chaudhuri12, Georg Ebersbach13.   

Abstract

Data on frequency, severity and correlations of NMS with motor complications are only available for a limited number of NMS. The NMS Scale (NMSS) is a validated tool to assess a broad range of NMS, which has not been used in NMS fluctuations. We assessed fluctuations of a broad range of non-motor symptom (NMS) for a 1-month time period in fluctuating Parkinson's disease (PD) in a multicenter cross-sectional study using the NMSS assessing NMS in motor On (NMSSOn) and Off state (NMSSOff) combined with clinical NMS and motor function scoring in 100 fluctuating PD patients. ΔNMSSOn/Off was defined as the differences of NMSS scores between On and Off. Complete NMSS datasets were available from 73 patients (53 % men; age: 68.2 ± 9.7 years) with mean total NMSS score in On state of 41.5 ± 37.6 and in Off state of 75.6 ± 42.3 (P < 0.001). Scores were higher in Off compared to On state for all domains except for domain "perceptual problems/hallucinations" (P = 0.608). Clinimetric properties of the NMSS were similar to those reported previously for NMS assessments independent of motor oscillations. NMSSOn, NMSSOff and ΔNMSSOn/Off showed weak to moderate correlations with demographics, indicators of motor symptom severity as well as with other measures of NMS, depression and quality of life. Correlations of NMSS items/domains with independent measures of related constructs were weak to moderate. In conclusion, when assessed with the NMSS, a broad range of NMS fluctuate with motor oscillations, but these fluctuations do neither correlate with motor function nor with measures of disease progression.

Entities:  

Keywords:  Apathy; Autonomic dysfunction; Depression; Motor complications; Non-motor fluctuations; Non-motor symptoms; Parkinson’s disease; Quality of life (QoL)

Mesh:

Year:  2015        PMID: 26264174     DOI: 10.1007/s00702-015-1437-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  33 in total

1.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

2.  The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Monica M Kurtis; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  Clinical approach to nonmotor sensory fluctuations in Parkinson's disease.

Authors:  Kemal Bayulkem; Grisel Lopez
Journal:  J Neurol Sci       Date:  2011-08-27       Impact factor: 3.181

6.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

7.  International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Authors:  P Martinez-Martin; C Rodriguez-Blazquez; K Abe; K B Bhattacharyya; B R Bloem; F J Carod-Artal; R Prakash; R A J Esselink; C Falup-Pecurariu; M Gallardo; P Mir; Y Naidu; A Nicoletti; K Sethi; Y Tsuboi; J J van Hilten; M Visser; M Zappia; K R Chaudhuri
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

8.  Aminergic systems in Alzheimer's disease and Parkinson's disease.

Authors:  R J D'Amato; R M Zweig; P J Whitehouse; G L Wenk; H S Singer; R Mayeux; D L Price; S H Snyder
Journal:  Ann Neurol       Date:  1987-08       Impact factor: 10.422

9.  Pain intensity on and off levodopa in patients with Parkinson's disease.

Authors:  Angelika Nebe; Georg Ebersbach
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

10.  A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.

Authors:  Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; David J Brooks; Fabrizio Stocchi; Per Odin; Angelo Antonini; Richard G Brown; Richard J Brown; Pablo Martinez-Martin
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more
  13 in total

Review 1.  Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.

Authors:  Joseph Classen; Jiri Koschel; Christian Oehlwein; Klaus Seppi; Peter Urban; Christian Winkler; Ullrich Wüllner; Alexander Storch
Journal:  J Neural Transm (Vienna)       Date:  2017-07-12       Impact factor: 3.575

2.  The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Authors:  Joaquin A Vizcarra; Álvaro Sánchez-Ferro; Walter Maetzler; Luca Marsili; Lucia Zavala; Anthony E Lang; Pablo Martinez-Martin; Tiago A Mestre; Ralf Reilmann; Jeffrey M Hausdorff; E Ray Dorsey; Serene S Paul; Judith W Dexheimer; Benjamin D Wissel; Rebecca L M Fuller; Paolo Bonato; Ai Huey Tan; Bastiaan R Bloem; Catherine Kopil; Margaret Daeschler; Lauren Bataille; Galit Kleiner; Jesse M Cedarbaum; Jochen Klucken; Aristide Merola; Christopher G Goetz; Glenn T Stebbins; Alberto J Espay
Journal:  Mov Disord       Date:  2019-03-22       Impact factor: 10.338

3.  Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease.

Authors:  Alexander Storch; Kristina Rosqvist; Georg Ebersbach; Per Odin
Journal:  J Neural Transm (Vienna)       Date:  2019-06-19       Impact factor: 3.575

4.  The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease.

Authors:  Lana M Chahine; Briana Edison; Margaret Daeschler; Sneha Mantri; Steven Kahl; Robyn Rapoport; Arina Goyle; Chelle Precht; Catherine Kopil; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2020-03-05

5.  Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?

Authors:  Eleonora Del Prete; Emmanuelle Schmitt; Sara Meoni; Valerie Fraix; Anna Castrioto; Pierre Pelissier; Roberto Ceravolo; Elena Moro
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.307

6.  Correlation of Quantitative Motor State Assessment Using a Kinetograph and Patient Diaries in Advanced PD: Data from an Observational Study.

Authors:  Christiana Ossig; Florin Gandor; Mareike Fauser; Cecile Bosredon; Leonid Churilov; Heinz Reichmann; Malcolm K Horne; Georg Ebersbach; Alexander Storch
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

7.  Associations Between Fluctuations in Daytime Sleepiness and Motor and Non-Motor Symptoms in Parkinson's Disease.

Authors:  Arja Höglund; Peter Hagell; Jan-Erik Broman; Sven Pålhagen; Kimmo Sorjonen; Sten Fredrikson; Per Svenningsson
Journal:  Mov Disord Clin Pract       Date:  2020-10-26

Review 8.  Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.

Authors:  Vanessa Raeder; Iro Boura; Valentina Leta; Peter Jenner; Heinz Reichmann; Claudia Trenkwalder; Lisa Klingelhoefer; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2021-02-09       Impact factor: 5.749

9.  Artificial Intelligent Olfactory System for the Diagnosis of Parkinson's Disease.

Authors:  Wei Fu; Linxin Xu; Qiwen Yu; Jiajia Fang; Guohua Zhao; Yi Li; Chenying Pan; Hao Dong; Di Wang; Haiyan Ren; Yi Guo; Qingjun Liu; Jun Liu; Xing Chen
Journal:  ACS Omega       Date:  2022-01-26

10.  Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.

Authors:  Avner Thaler; Nurit Omer; Nir Giladi; Tanya Gurevich; Anat Bar-Shira; Mali Gana-Weisz; Orly Goldstein; Meir Kestenbaum; Julia C Shirvan; Jesse M Cedarbaum; Avi Orr-Urtreger; Keren Regev; Shani Shenhar-Tsarfaty; Anat Mirelman
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.